针灸治疗帕金森症?中国科学家揭示其分子机制

2016-02-01 佚名 上海应用物理研究所

中国科学院上海应用物理研究所物理生物学研究室通过与上海中医药大学针灸经络研究所、针灸推拿学院以及龙华医院针灸科等单位合作,在帕金森症(Pakinson's disease)小鼠模型上探索了针灸作用的分子机制。研究发现,针刺小鼠腿部的阳陵泉穴可以通过非mTOR依赖途径调节脑内多巴胺能神经元的自噬通路,恢复其受损的自噬(autophagy)水平,清除α-突触核蛋白(α-synuclein)在脑内的

中国科学院上海应用物理研究所物理生物学研究室通过与上海中医药大学针灸经络研究所、针灸推拿学院以及龙华医院针灸科等单位合作,在帕金森症(Pakinson's disease)小鼠模型上探索了针灸作用的分子机制。研究发现,针刺小鼠腿部的阳陵泉穴可以通过非mTOR依赖途径调节脑内多巴胺能神经元的自噬通路,恢复其受损的自噬(autophagy)水平,清除α-突触核蛋白(α-synuclein)在脑内的积累,并显着改善其运动能力。相关研究论文Acupuncture promotes mTOR-independent autophagic clearance of aggregation-prone proteins in mouse brain 于近日发表在《科学报告》(Scientific Reports)上。

针灸疗法在我国已有几千年的历史,是通过针刺或艾灸特定穴位来达到防病治病的目的。目前,针灸在国际医学界已开始得到越来越广泛的认可,关于其分子机制的研究也引起了广泛关注。例如,美国研究者已揭示了针灸镇痛和电针抗炎的分子机制(Goldman et al. Nature Neuroscience, 2010, 13, 883; Torres-Rosas et al. Nature Medicine, 2014, 20, 291)。神经退行性疾病(帕金森症状、阿尔兹海默症、亨廷顿式病等)是一类对人类具有重大威胁的疾病。针灸对缓解其症状具有明确疗效,但其分子机制尚不清晰。

自噬是真核生物中对细胞内物质进行周转的重要过程,且在进化中高度保守。研究表明自噬通路障碍与众多疾病包括神经退行性疾病的发生发展具有相关性。近年来一些工作还证明了锻炼和机械刺激等可以通过调控细胞和机体的自噬水平来发挥作用(例如He et al. Nature, 2012, 481, 511)。

受此启发,上海应物所研究员樊春海、胡钧和副研究员孙艳红与上海中医药大学教授吴焕淦、裴建等组成合作研究团队,探索针灸作为一种特殊的机械刺激,能否通过调控机体的自噬水平来起到对神经退行性疾病的治疗作用。田甜等研究人员在帕金森症模型小鼠中考察了针刺前后脑内自噬相关指标的变化。研究表明,针刺阳陵泉穴能够显着上调小鼠脑内多巴胺能神经元的溶酶体膜蛋白表达,并修复受阻断的自噬—溶酶体通路。自噬水平的上调抑制了帕金森症的标志性病理蛋白α-突触核蛋白(α-synuclein)在小鼠脑内的积累。随着自噬水平的恢复,小鼠的多巴胺能神经元损伤获得改善、多巴胺能神经元的活力和运动行为学能力得到显着提升。进一步研究表明,这种针刺诱导的自噬水平上调不依赖于mTOR通路。这种特性区别于常用的自噬诱导剂(如雷帕霉素,rapamycin),而且针灸作为一种物理疗法,为避免化学药物的副作用和避开化学药物递送中血脑屏障问题提供了新的可能。因此,这项研究不仅从自噬角度探索了针灸改善神经退行性病变的分子机制,而且为针灸这一古老中医疗法在神经退行性疾病和衰老等方面的应用提供了有益的思路。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
    2016-02-19 1de522f9m41(暂无匿称)

    学习,可以试验

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
    2016-02-03 howi
  6. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
    2016-02-02 李继凯

    中医博大精深

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
    2016-02-02 李继凯

    赞一个

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2055503, encodeId=a4362055503df, content=<a href='/topic/show?id=3b2096294d7' target=_blank style='color:#2F92EE;'>#针灸治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96294, encryptionId=3b2096294d7, topicName=针灸治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5632, createdName=jianjun66, createdTime=Sun Apr 03 17:25:00 CST 2016, time=2016-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024244, encodeId=a4a3202424428, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sun Sep 25 01:25:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64743, encodeId=cd2f64e43f5, content=学习,可以试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c3d1688961, createdName=1de522f9m41(暂无匿称), createdTime=Fri Feb 19 08:44:00 CST 2016, time=2016-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516905, encodeId=c4ee151690535, content=<a href='/topic/show?id=f1232194031' target=_blank style='color:#2F92EE;'>#中国科学家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21940, encryptionId=f1232194031, topicName=中国科学家)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbca11021083, createdName=12498e5fm15(暂无昵称), createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518863, encodeId=0a481518863dd, content=<a href='/topic/show?id=2ad14853585' target=_blank style='color:#2F92EE;'>#帕金森症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48535, encryptionId=2ad14853585, topicName=帕金森症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6811200125, createdName=howi, createdTime=Wed Feb 03 00:25:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62709, encodeId=932262e0990, content=中医博大精深, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62710, encodeId=cf2562e101d, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Tue Feb 02 01:05:00 CST 2016, time=2016-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62593, encodeId=9f096259356, content=中医还是有很多启发性的东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=201b1682212, createdName=1de398e9m17(暂无匿称), createdTime=Mon Feb 01 22:25:00 CST 2016, time=2016-02-01, status=1, ipAttribution=)]
    2016-02-01 1de398e9m17(暂无匿称)

    中医还是有很多启发性的东西

    0

相关资讯

AIM:亚力山大健身技术或针灸可显著改善慢性颈痛

慢性颈部疼痛管理可能受益于更多的积极自我保健为导向的方法。该研究的目的为了评估亚历山大技术或针灸与常规治疗相比,对于治疗慢性非特异性颈痛者的临床效果。该三组随机,对照试验在英国初级卫生保健中心进行。参与者为颈部疼痛持续至少3个月,颈部疼痛和相关残疾的Northwick Park问卷(NPQ)至少有28%的得分,而且并没有严重的潜在病变。干预方法为12个针灸疗程或20个一对一的亚历山大课程(共有60

Endocrinology:针灸有利于减轻焦虑和抑郁情绪

来自乔治城大学医学中心(GUMC)的研究人员表示,进行动物研究为中国探究慢性病治疗机制提供了强有力的证据。Ladan Eshkevari博士(GUMC护理系、药理学和生理学副教授、麻醉护士、注册针灸师)说:“针灸的好处是众所周知的,且是有证据基础的。这项研究的重点在于演示针灸是如何作用于机体,并使得接受治疗的患者减轻压力和疼痛、解除抑郁情绪的。现在我们已经发现了针灸潜在的作用机制,但是我们需要采用

BMJ Open:小心庸医!上海不建议使用针灸治疗婴幼儿

当代上海中医药从业人员不推荐使用针灸治疗婴幼儿。针灸对婴幼儿疾病有广泛适应症似乎是西医经验,没有多少中医药学现代实践基础。

Med Acupunct:针灸可有效治疗轻中度高血压,降低中风及心脏病的发病风险

近日有研究表明,针灸治疗高血压患者可使其血压下降并可保持一个半月,该研究成果发表于《Medical Acupuncture》。该研究首次证实了,针灸可有助于轻至中度高血压的治疗,而且研究表明,定期接受针灸治疗可帮助高血压患者控制血压并较少其中风及心脏病的发病风险。来自加利福尼亚大学的心脏病专家Dr. John

AIM:对于更年期潮热:中医针灸不优于非插入性假针灸

潮热(HFs)影响了高达75%的更年期女性,并造成相当大的健康和经济负担。针灸作为HF治疗疗效的证据是相互矛盾的。该研究的目的是评估中医针灸 vs 假针灸对于更年期HFs的疗效。这是一项分层,盲(参加者,结果评估员和调查员,但不是治疗的针灸师),平行,随机,假对照的平均分配试验,该试验在澳大利亚的社区进行。该研究的参与者为晚期绝经过渡期和绝经后的女性,年龄大于40岁,每天至少有7次中度HFs,符合